- Report
- January 2024
- 150 Pages
Global
From €4689EUR$4,850USD£4,030GBP
- Report
- April 2024
- 182 Pages
Global
From €4785EUR$4,950USD£4,113GBP
- Report
- April 2024
- 184 Pages
Global
From €4785EUR$4,950USD£4,113GBP
- Clinical Trials
- April 2024
- 250 Pages
Global
From €2417EUR$2,500USD£2,077GBP
- Report
- October 2023
- 180 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- September 2023
- 111 Pages
Global
From €2417EUR$2,500USD£2,077GBP
- Report
- June 2023
- 862 Pages
Global
From €2417EUR$2,500USD£2,077GBP
- Report
- April 2024
- 450 Pages
Global
From €3862EUR$3,995USD£3,319GBP
- Report
- September 2023
- 135 Pages
Global
From €4350EUR$4,500USD£3,739GBP
- Report
- March 2024
- 221 Pages
Global
From €2368EUR$2,450USD£2,036GBP
- Report
- October 2023
- 145 Pages
Global
From €2416EUR$2,499USD£2,076GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1450EUR$1,500USD£1,246GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1933EUR$2,000USD£1,662GBP
- Clinical Trials
- April 2024
- 180 Pages
Global
From €2417EUR$2,500USD£2,077GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1933EUR$2,000USD£1,662GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1450EUR$1,500USD£1,246GBP
- Drug Pipelines
- April 2024
- 202 Pages
Global
From €7685EUR$7,950USD£6,606GBP
- Report
- January 2024
- 169 Pages
Global
From €7250EUR$7,500USD£6,232GBP
- Report
- January 2024
- 84 Pages
Global
From €3819EUR$3,950USD£3,282GBP
- Report
- November 2023
- 148 Pages
Global
From €4302EUR$4,450USD£3,698GBP
The Lupus Drug market is a subset of the Immune Disorders Drugs market, which focuses on treatments for autoimmune diseases such as lupus. Lupus is a chronic, autoimmune disorder that can cause inflammation, pain, and tissue damage in various parts of the body. Lupus drugs are used to reduce inflammation, suppress the immune system, and reduce the risk of organ damage. These drugs are typically prescribed in combination with other treatments such as lifestyle changes, physical therapy, and other medications.
The Lupus Drug market is highly competitive, with a range of products available from both generic and branded manufacturers. Companies in the market include AbbVie, Bristol-Myers Squibb, GlaxoSmithKline, Novartis, Pfizer, and Roche. Show Less Read more